Helius Medical Technologies is trading at $2.22, down 5.54%, with no company-specific announcement explaining the decline found in available search results.
- The latest company-specific coverage found was not a clear catalyst for October 16.
- Broad market weakness coincided with the decline: the S&P 500 fell 1.31% and Nasdaq fell 2.39%. This is context, not a confirmed direct cause.
- Live-session volume was unavailable in the supplied price context and search results.